Cargando…

Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration

BACKGROUND: Citrate, the currently preferred anticoagulant for continuous veno-venous hemofiltration (CVVH), may influence acid-base equilibrium. METHODS: The effect of 2 different citrate solutions on acid-base status was assessed according to the Stewart-Figge approach in two consecutive cohorts o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, Rita, Honore, Patrick M., Diltoer, Marc, Spapen, Herbert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000455/ https://www.ncbi.nlm.nih.gov/pubmed/27562561 http://dx.doi.org/10.1186/s12882-016-0334-3

Ejemplares similares

Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2020)

Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration
por: Spapen, Herbert, et al.
Publicado: (2019)

CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

Correction to: CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

Catheter Port Reversal in Citrate Continuous Veno-Venous Hemofiltration
por: Boer, Willem, et al.
Publicado: (2021)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Continuous veno-venous hemofiltration in patients with metformin associated lactic acidosis
por: Bethlehem, C, et al.
Publicado: (2015)

Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
por: Köglberger, Paul, et al.
Publicado: (2021)

Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution
por: Morabito, Santo, et al.
Publicado: (2012)

Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury
por: Liu, De-Lin, et al.
Publicado: (2016)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Effectiveness of continuous veno-venous hemofiltration in the treatment of severe acute pancreatitis
por: Chen, Xuan, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Anti-infective Agents during Continuous Veno-venous Hemofiltration in Critically Ill Patients: Lessons Learned from an Ancillary Study of the IVOIRE Trial
por: Breilh, Dominique, et al.
Publicado: (2019)

Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children
por: Bai, Ke, et al.
Publicado: (2019)

Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration
por: Van Matre, Edward T., et al.
Publicado: (2017)

Renal tubular acidosis with hyperchloremic acidosis: harmless with a sting?
por: Honore, Patrick M., et al.
Publicado: (2015)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Improvement of Oxygenation in Severe Acute Respiratory Distress Syndrome With High-Volume Continuous Veno-venous Hemofiltration
por: Yang, Wenmin, et al.
Publicado: (2016)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report
por: Wu, Buyun, et al.
Publicado: (2018)

Arterio- and veno-venosus hemofiltration in the treatment of sepsis and septic shock
por: Marjanek, Zs, et al.
Publicado: (2002)

Continuous veno-venous hemofiltration for treatment of enterovirus 71-induced fulminant cardiopulmonary failure: a case report
por: Phan, Phuc Huu, et al.
Publicado: (2012)

Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury
por: Yang, Yi, et al.
Publicado: (2013)

Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study
por: Wu, Buyun, et al.
Publicado: (2014)

A Case-Control Study of Continuous Veno-Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis
por: Liu, Yan, et al.
Publicado: (2022)

Metabolic and coagulation effects of citrate: down to the last detail!
por: Honore, Patrick M., et al.
Publicado: (2015)

Veno-venous extracorporeal CO(2) removal for the treatment of severe respiratory acidosis
por: Cove, Matthew E, et al.
Publicado: (2015)

Clinical effects of continuous veno-venous hemofiltration combined with hemoperfusion for the treatment of multiple myeloma complicated with acute kidney injury
por: Huang, Jing, et al.
Publicado: (2023)

Retracted: A Case-Control Study of Continuous Veno-Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight!
por: Honore, Patrick M., et al.
Publicado: (2016)

Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia?
por: Honore, Patrick M., et al.
Publicado: (2018)

Alterations in the elastic properties of the blood clots after the application of the continuous veno-venous hemofiltration in patients submitted to on-pump cardiac surgery
por: Pispirigkou, S, et al.
Publicado: (2013)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study
por: Yu, Yan, et al.
Publicado: (2020)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
por: Ratanarat, Ranistha, et al.
Publicado: (2023)

Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution
por: Jeffrey, Yuen Henry, et al.
Publicado: (2017)

Citrate: How to Get Started and What, When, and How to Monitor?
por: Honore, Patrick M., et al.
Publicado: (2018)

Impact of Continuous Veno-Venous HemoDiALYsis with Regional Citrate Anticoagulation on Non-NUTRItional Calorie Balance in Patients on the ICU—The NUTRI-DAY Study
por: Wechselberger, Simon, et al.
Publicado: (2022)

Veno-venous extracorporeal CO(2) removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations
por: Karagiannidis, Christian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ir07gd6vqreaaros1u4u6jhr2b